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Molecular tweezers (MTs) are supramolecular host molecules equippedwith two aromatic
pincers linked together by a spacer (Gakh, 2018). They are endowed with fascinating
properties originating from their ability to hold guests between their aromatic pincers
(Chen and Whitlock, 1978; Zimmerman, 1991; Harmata, 2004). MTs are finding an
increasing number of medicinal applications, e.g., as bis-intercalators for DNA such
as the anticancer drug Ditercalinium (Gao et al., 1991), drug activity reverters such
as the bisglycoluril tweezers Calabadion 1 (Ma et al., 2012) as well as radioimmuno
detectors such as Venus flytrap clusters (Paxton et al., 1991). We recently embarked
on a program to create water-soluble tweezers which selectively bind the side chains
of lysine and arginine inside their cavity. This unique recognition mode is enabled by a
torus-shaped, polycyclic framework, which is equipped with two hydrophilic phosphate
groups. Cationic amino acid residues are bound by the synergistic effect of disperse,
hydrophobic, and electrostatic interactions in a kinetically fast reversible process.
Interactions of the same kind play a key role in numerous protein-protein interactions,
as well as in pathologic protein aggregation. Therefore, these particular MTs show a
high potential to disrupt such events, and indeed inhibit misfolding and self-assembly of
amyloidogenic polypeptides without toxic side effects. The mini-review provides insight
into the unique binding mode of MTs both toward peptides and aggregating proteins. It
presents the synthesis of the lead compound CLR01 and its control, CLR03. Different
biophysical experiments are explained which elucidate and help to better understand
their mechanism of action. Specifically, we show how toxic aggregates of oligomeric
and fibrillar protein species are dissolved and redirected to form amorphous, benign
assemblies. Importantly, these new chemical tools are shown to be essentially non-toxic
in vivo. Due to their reversible moderately tight binding, these agents are not protein-,
but rather process-specific, which suggests a broad range of applications in protein
misfolding events. Thus, MTs are highly promising candidates for disease-modifying
therapy in early stages of neurodegenerative diseases. This is an outstanding example
in the evolution of supramolecular concepts toward biological application.
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INTRODUCTION
A major challenge in modern medicine is the field of
neurodegenerative diseases. Their pathology is dominated
by misfolding and subsequent aggregation of characteristic
peptides or proteins in the brain, which is correlated with severe
impairment of cognitive functions. As the most prominent
example, the amyloid β-peptide (Aβ) plays a key role in the
development and progression of Alzheimer’s disease (AD)
(Hardy and Higgins, 1992; Hardy and Selkoe, 2002). Senile
plaques composed of aggregated Aβ , forming extracellular
β-sheet fibril morphologies, are histopathological hallmarks
found in the brains of AD patients. In recent years however,
small soluble Aβ oligomers were identified as the most
neurotoxic species (Shankar et al., 2008; Zhao et al., 2012;
Sengupta et al., 2016). Despite intense research, the underlying
mechanisms of spontaneous misfolding, aggregation, and
lesion of nerve cells are still poorly understood. To date
only symptom-relieving drugs are clinically approved for
AD treatment. Strategically, it seems desirable to develop
drug candidates which are able to interfere with the early
stages of the disease mechanism. Classical approaches
include the reduction of Aβ production by inhibitors of β-
and γ - secretase, the increase of Aβ removal via anti-Aβ
immunotherapy, and direct interference with Aβ aggregation
(Hardy and Selkoe, 2002; Roland and Jacobsen, 2009). The
latter can be achieved with a diverse set of peptides and small
molecules. Well-known milestones in this field are Congo
red (Podlisny et al., 1998), scyllo-Inositol (McLaurin et al.,
2000), amino-propane sulfonic acid (Gervais et al., 2007),
Clioquinol (Cherny et al., 2001), methylene blue (Necula
et al., 2007), and polyphenol (–)-epigallocatechin (EGCG)
(Ehrnhoefer et al., 2008).
However, some of these compounds are toxic, others
are only active in cell culture or animal experiments, and
until today no drug candidate made it through clinical trial.
In addition, little structural information is available about
the direct interaction between Aβ and most aggregation
inhibitors. Thus, there is clearly a need for new rational
approaches. Supramolecular Chemistry has gained a much-
improved understanding and quantitative description of
those non-covalent interactions which are involved in protein
aggregation. In addition, molecular modeling now allows
extended MD simulations of complex ensembles with large
sampling times and discrete solvent treatment—resulting in
predictive power for new supramolecular binders. In our
group we developed a highly selective host molecule for
lysine and arginine, which is able to draw their side chains
into its cavity and shield them from the environment. These
molecular tweezers turned out to completely disrupt existing
β-sheets formed by amyloidogenic proteins. Our discovery
started an intense and very fruitful collaboration between
supramolecular chemists and neurologists, which has reached
the state of animal experiments and behavioral testing with
transgenic mice and holds promise for the development of
disease-modifying therapy. This mini-review summarizes
the chemical aspects of the endeavor—from deciphering the
binding mode of the tweezers over structural elucidation of their
complexes with aggregating proteins to the characterization
of their anti-aggregatory effect on various proteins. Finally,
toxicity, metabolism, and bioavailability issues will also be
briefly discussed.
THE DEVELOPMENT OF MOLECULAR
TWEEZERS AS LYSINE AND ARGININE
BINDERS
Structure and Binding Mode of Molecular
Tweezers
There are numerous artificial binding motifs for naturally
occurring amino acids, but only a few of them are selective and
mild enough to find biological application (Crini, 2014; Barrow
et al., 2015; Neri et al., 2016). Molecular tweezers were designed
rationally, combining supramolecular knowledge, and total
synthesis to obtain water-soluble horseshoe-shaped molecules.
They are characterized by their well-preorganized torus-shaped,
polycyclic non-polar framework, equipped with two hydrophilic
phosphate groups. The uniqueness of MTs is reflected in
their capability to selectively accommodate exclusively the
side chains of basic amino acids, namely lysine and arginine,
inside their cavity under physiological conditions. Electrostatic
potential surface (EPS) calculations demonstrate that their cavity
construction is electron-rich, perfectly symmetric, and open
to receive cationic appropriately shaped guests (Figure 1B). It
appears that even in PBS buffer tweezer dimerization is negligible
(Dutt et al., 2013; Heid et al., 2018).
MTs bind cationic amino acid residues via threading their
side chains through the cavity in a non-covalent fashion followed
by formation of a salt bridge between the tweezer phosphate
and the included ammonium or guanidinium cation. This is
facilitated by exploiting in a synergistic way van der Waals
interactions, substantial electrostatic contributions, and the non-
classical hydrophobic effect; this binding mode results in a
kinetically fast and reversible recognition process. Quantum
chemical and molecular mechanics (QM/MM) calculations and
various analytical experiments strongly support this postulated
binding mode between MTs and their amino acid guests.
Monte Carlo (MC) and molecular dynamics (MD) simulations,
isothermal titration calorimetry (ITC) measurements, NMR,
and fluorescence titrations, as well as NOESY and variable
temperature (VT) experiments clearly point to inclusion of
the lysine and arginine side chain inside the tweezer cavity in
an enthalpy-driven process. QM/MM calculations confirm the
existence of these favorable host-guest complexes in buffered
aqueous solution formed via the threading mode (Fokkens et al.,
2005; Dutt et al., 2013).
Recently, a crystal structure of the complex between MT and
a 14-3-3 protein beautifully demonstrated the threading of the
well accessible Lys-214 side chain through the tweezers’ cavity
accompanied in solution with a substantial inhibition of the
complex formation between the 14-3-3 and its natural cargo
proteins (Bier et al., 2013).
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FIGURE 1 | (A) Synthesis of the molecular tweezer CLR01 (Talbiersky et al., 2008) and negative control CLR03 (Kirsch et al., 2009). (B) Electrostatic Surface Potential
of CLR01 calculated by PM3 implemented in SPARTAN 04 (Wavefunction Inc.) Color code spans from −25 kcal/mol (red) to +25 kcal/mol (blue), taken from (Heid
et al., 2018, Figure 5). (C) 2Fo–Fc electron density (contoured at 1s) for the molecular tweezers bound to 14-3-3σ (Bier et al., 2013, Figure 4B).
Tweezer Synthesis
The characteristic MT framework consists of nine annulated
6-membered rings, which are alternating phenyl and
norbornadiene ring systems. The construction of this
hydrocarbon torus is achieved in the key step via double
Diels-Alder (DA) cycloaddition using two equivalents of diene
1 which forms the walls and one equivalent of dienophile 2
which is the center-piece (Figure 1A). The exocyclic diene is
obtained in six steps from indene and maleic acid anhydride
while the dienophile is made from 1,4-benzophenone in a
four-step sequence. The neutral DA reaction requires elevated
temperatures; it proceeds stereoselectively endo in 1 and exo
in 2 and thus leads after DDQ (2,3-dichloro-5,6-dicyano-1,4-
benzoquinone) oxidation to the desired tweezer (3) having
the four methylene bridges in all-syn configuration (Klärner
et al., 1996, 1999; Talbiersky et al., 2008; Schrader et al., 2016).
The two acetoxy-groups can be cleaved in a symmetric or
asymmetric fashion, releasing hydroquinone OH groups which
can be further functionalized with negatively charged groups
for enhanced water-solubility (e.g., phosphates, carboxylates,
and sulfates) (Dutt et al., 2013). In the course of several years of
intense biophysical and biological testing, the tweezers CLR01
with its two phosphate esters evolved as a lead compound, while
its truncated derivative without the side walls, CLR03, served as
a negative control. CLR03 represents the central part of the MT
molecule; due to the lack of the torus-shaped cavity, it is not able
to bind Lys and Arg by inclusion (Schrader et al., 2016).
INTERACTION WITH BIOACTIVE PEPTIDES
CLR01 was initially tested with small, biologically relevant
small peptides (Fokkens et al., 2005). The KLVFF peptide
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is located inside the central hydrophobic part of the
amyloid-β protein, and it was identified as a nucleation
site for pathologic protein aggregation, fibril formation, and
subsequent plaque occurrence in Alzheimer’s disease. NMR
and fluorescence titrations with this small peptide revealed
inclusion of the N-terminal lysine inside CLR01 and a moderate
affinity of 10 µM (Kd) in buffered aqueous solution (PBS)
(Dutt et al., 2013).
ITC measurements provide further insight into the postulated
binding mode. The binding event between host CLR01 and
its KLVFF guest was shown to be a favorable, strongly
exothermic process. Here the MT peptide affinity was found
to be 15 µM, with a 1:1 stoichiometry, and an enthalpic
contribution 1H of −6.6 kcal/mol, which is prevailing over
the small entropy term –T1S of −0.2 kcal/mol. Arginine
complexation in other peptides was found to be slightly weaker,
in the range of 30 µM, most likely due to its delocalized
guanidinium ion and shorter side chain. The remarkably
exothermic character of the binding event correlates well with
the assumed threading procedure and the resulting van der
Waals interactions between the host cavity and the respective
amino acid side chain. The above-reported Kd values, although
moderate in biological terms, place these MT among the most
efficient receptor molecules for basic amino acids known today
(Fokkens et al., 2005; Dutt et al., 2013).
In general, dissociation constants obtained from ITC
measurements agree well with the data determined
independently by fluorescence or 1H NMR titrations, in
spite of the different concentration regimes (NMR 10−3 M, ITC
10−4 M, Fluoresc. 10−5 M). The emission intensity maximum of
MTs in fluorescence spectra is found around 330 nm, while the
excitation maximum is located at 285 nm (pi,pi∗). Trapping of
guest molecules inside the tweezers cavity results in significant
quenching of the fluorescence emission. This proves guest
inclusion and allows quantification of the binding event at
low concentrations. In most cases affinities for a single lysine
inclusion determined by fluorometric titrations are in the range
of 5–20 µM Kd. Structurally, the MT’s preference for lysine
inclusion has been proven in numerous 1H NMR titrations
in buffer, which reveal drastic upfield shifts of up to 4 ppm
(δ1max) at the δ- and ε- methylene protons of the basic amino
acid side chains. NOESY measurements as well as variable
temperature experiments strongly support the guest inclusion
(Fokkens et al., 2005).
Molecular tweezers with their unique binding mode for
lysine and arginine and their unexpected powerful effect as
aggregation inhibitors have attracted the attention of many
research groups worldwide in the last decade. Numerous
fruitful collaborations demonstrated that these lysine binders
represent a widely applicable useful tool against pathologic
protein misfolding. In addition, sophisticated analytical methods
opened our understanding of the underlying supramolecular
mechanism of action. Today we know that advancedMTs are able
to specifically disrupt undesired protein-protein interactions;
however perhaps even more important is the fact that MTs
indeed inhibit misfolding and self-assembly of amyloidogenic
polypeptides without toxic side effects (Sinha et al., 2011).
INTERACTION BETWEEN MOLECULAR
TWEEZERS AND AGGREGATING
PROTEINS
The pathogenesis of every amyloidosis is caused by aberrant
protein aggregation and most likely begins with protein
misfolding. AD, Parkinson’s disease and type-2 diabetes are
the best examined examples of this pathologic process. In
the course of AD, the largely unstructured naturally occurring
monomeric state of the amyloid-β peptides was shown to adopt a
conformation rich in β-sheets and which aberrantly forms toxic
oligomers and aggregates (Billings et al., 2005). Aβ40, Aβ42 and
the group of tau proteins mainly participate in this neurologically
highly relevant aggregation process which ultimately disposes
extracellular plaque formed from β-sheet-rich fibrils. Lysine
residues are reported to play an important role in this particular
assembly (Usui et al., 2009; Sinha et al., 2012).
Gratifyingly, MT were found to interfere with the aggregation
process of most amyloidogenic proteins. In recent years,
many different experiments have been designed and conducted
which confirmed CLR01 to be capable of dissolving fibrils,
preventing their formation as well as eliminating their toxic
precursor oligomers. Structurally, it was important to identify
the tweezer binding sites on these proteins. For the most
prominent representative, the Alzheimer’s peptide, the preferred
complexation sites of the tweezers were validated by electron
capture dissociation (ECD) mass experiments (EDC-MS/MS) as
well as by NMR spectroscopy (Sinha et al., 2011).
ECD-MS/MS
In the monomeric form of Aβ40 and Aβ42 there are three
basic residues, Arg-5, Lys-16, and Lys-28. All of these are
simultaneously complexed as confirmed by mass spectrometry.
In EDC-MS/MS experiments complexes of MT and a Aβ protein
were collected in a linear ion trap and smoothly fragmented
inside. The recorded MS spectra found MT bound to many
overlapping protein fragments. The mass spectra show peaks
for Aβ40 bound by one, two and three MTs, respectively. In
the fragmentation pattern CLR01-Aβ-fragment peaks were only
found for fragments bearing a Lys or Arg residue, indicating
a retained amino acid selectivity in Aβ complexation. Most
importantly, peptide cleavage did not occur around the two lysine
binding sites, because these were protected by the tweezers. The
exact binding mode of this complexation event was subsequently
investigated by NMR experiments (Sinha et al., 2011).
NMR Experiments
1H–15N and 1H–13C heteronuclear single quantum coherence
(HSQC) NMR experiments confirmed these results. An HSQC
spectrum of Aβ40 alone and together with 0.5 equivalents of
MT were compared. Upon tweezer binding, the cross peaks
of the complexed residue as well as its neighboring amino
acids show a significant chemical shift perturbation (CSP) due
to the altered magnetic environment. Some signals vanished
completely, indicated by red circles in Figure 2A. In two-
dimensional H(N)CO experiments MT were titrated to a protein
solution; already at a 1:10 ratio of CLR01 relative to Aβ40 the CSP
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FIGURE 2 | (A) 15N–1H HSQC spectrum of Aβ40 in the presence of 30 µM CLR01 (cyan). Red circles indicate resonances that disappeared completely upon addition
of CLR01 to Aβ40 solution (Sinha et al., 2011). (B) Time-dependent ThT fluorescence intensities of incubated solution of: pure IAPP (red); IAPP + CLR01 (1:1) (blue);
IAPP+CLR03 (1:1) (green) (Sinha et al., 2011). (C) EM images of the solutions after titration. CLR01 (middle) clearly shows inhibition of fibril formation (Sinha et al.,
2011). (D) Effects CLR01 on Aβ42 early oligomerization. Arrival time distributions (by ion-mobility spectrometry) of z/n = −5/2 Aβ42 (m/z = 1805) in an Aβ42 sample
without CLR01 (left) and z/n = −5/2 Aβ42 and CLR01 1:1-complex (m/z = 1,950). Oligomeric species (n = 6;12) vanish after CLR01 addition (Zheng et al., 2015).
became significant. Amino acid residues surrounding Lys-16 and
Lys-28 showed a higher degree of perturbation compared to those
in proximity to Arg-5. This implies a stronger affinity of MT for
the Aβ Lys residues, consistent with the general Lysine preference
of CLR01. At elevated CLR01 concentration all three positions
were occupied. The negative control CLR03 showed no effects
in the whole NMR-setup (Sinha et al., 2011). Similarly, a three-
dimensional HN(CO)CACB NMR experiment was recently used
to detect binding sites of MT in the phosphorylated and
unphosphorylated tau protein (Despres et al., 2019).
The combination of EDC-MS/MS and NMR spectroscopy
underlines the importance of the tweezer cavity for complex
formation with Aβ40 and Aβ42, and strongly supports the
binding mode elucidated with small peptides (Figure 1C).
If CLR01 binds to every sterically accessible basic residue on
a peptide or protein, why is it not toxic then? It was indeed
shown that the MT are non-toxic in biological applications
at concentrations necessary to inhibit protein aggregation. We
believe, that the key lies in kinetically fast reversible binding and
moderate affinity. Biophysical experiments indicate fast on and
off rates and labile complexation as well as moderate dissociation
constants in the low µM range (Talbiersky et al., 2008; Bier et al.,
2013). These key features of our MT safeguard healthy proteins
from damage induced by conformational changes, so that they
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retain their natural biological function. Indeed, enzymes could
be inhibited by MT, albeit only at millimolar concentrations,
100 times higher than those required for the anti-aggregatory
effect. The specificity of CLR01 toward the process of aberrant
protein aggregation is outstanding because it is a new principle
which may be transferred to other drugs as well. It appears that
MTs bind their protein guests with the same combination of
non-covalent interactions which is also active in the unwanted
aggregation process. This unique way of action toward protein
aggregation, represents the first example of a “process-specific”
aggregation inhibitor; it was examined with various biophysical
methods (Schrader et al., 2016).
PREVENTION OF PATHOLOGIC PROTEIN
AGGREGATION
Until 2011 experimental evidence was accumulated for the
fact that lysine-specific MT are active against a wide range of
aggregating proteins, with detailed experiments performed on
the assembly and toxicity of nine prominent amyloid proteins
(Sinha et al., 2011).
In this comprehensive investigation a synopsis of various
state-of-the-art biophysical experiments gave the full picture:
Thioflavin T (ThT) fluorescence, Electron Microscopy
(EM), Circular Dichroism spectroscopy (CD), Dynamic
Light Scattering (DLS), Mass Spectrometry (MS), and
NMR Spectroscopy.
Thioflavin T (ThT) Fluorescence
ThT is an amyloid dye indicator which turns highly fluorescent
upon binding to existing β-sheets (LeVine, 1999). ThT
fluorescence was used to monitor the kinetics of β-sheet
formation for various amyloid proteins in the presence or
absence of CLR01. The tweezers represented the active drug,
whereas their truncated derivative, CLR03, was used as negative
control. Measurements were performed regularly during a time
span of up to 120 h at pH 7.4 in 10 mM phosphate buffer.
CLR01 was added in up to 10-fold excess relative to the
protein and was able to completely suppress the typical drastic
fluorescence enhancement caused by aggregation and protein
misfolding. Equimolar concentration of CLR01 was likewise
shown to totally disrupt β-sheets of the tau protein. CLR03
displayed no effect in any of the investigated proteins because
it lacks the hydrophobic side walls and consequently, the ability
to complex Lys residues. Importantly, CLR01 not only inhibited
the de novo aggregation of amyloidogenic proteins such as
Aβ40/Aβ42, α-synuclein and IAPP (Figure 2B) (Prabhudesai
et al., 2012), but also disaggregated pre-formed fibrils over several
weeks when added at a 10-fold excess, as being confirmed
by EM.
Electron Microscopy (EM)
EM measurements were carried out in parallel to ThT assays, by
spotting 10 µL aliquots taken from each aggregation reaction,
on glow discharged, carbon-coated Formvar grids, using a
CX 100 transmission electron microscope. Visualization of the
protein morphology showed that IAPP and other examined
amyloidogenic protein samples incubated in the presence
of MTs did not form fibrils anymore, strongly supporting
conclusions drawn from the ThT measurements (Figure 2C)
(Sinha et al., 2011).
CD Spectroscopy
All β-sheets and therefore also all pathologic protein aggregates
produce a dominant characteristic β-sheet band at 215 nm
in the CD spectrum. In the presence of a 3-fold excess
of CLR01, this band was rapidly reduced and completely
disappeared after 1 h, indicating efficient inhibition of β-sheet
formation in case of Aβ40 and Aβ42. Equimolar CLR01 lead to
partial inhibition. Interestingly, CLR01 completely inhibited tau
aggregation already at the equimolar level, which correlates with
the higher number of exposed Lys residues in the tau sequence in
comparison to Aβ (Sinha et al., 2011).
Dynamic Light Scattering (DLS)
Dynamic light scattering provides a direct and non-invasive way
to monitor the formation of larger aggregates. It was employed to
monitor the influence of CLR01 on oligomer size and distribution
of Aβ. Experiments were performed with CLR01 in 10-fold
excess or equimolar relative to Aβ , controls were run with
Aβ alone. Intriguingly, the DLS results indicate that CLR01
does not prevent oligomer formation but rather modulates
Aß self-assembly into formation of structures that are neither
amyloidogenic nor toxic (Sinha et al., 2011).
Mass Spectrometry (MS)
In recent years, advanced methods in mass spectrometry have
been exploited for the mechanistic elucidation of protein
aggregating events. Thus, Bowers et al. used mild ionization
conditions and high resolution to monitor the impact of small
molecule modulators on Aβ oligomerization (Zheng et al., 2015).
The effect of different concentrations of CLR01 and its related
derivate, CLR03 on the Aβ assembly was investigated with
a custom-built ion mobility spectrometry-mass spectrometer
(IMS-MS) which consisted of a nano electrospray ionization
(nano-ESI) source, an ion funnel, a temperature-controlled drift
cell, and a quadrupole mass filter followed by an electron
multiplier for ion detection (Wyttenbach et al., 2001). Consistent
with earlier studies (Sinha et al., 2011), these experiments
confirmed Arg-5, Lys-16, and Lys-28 as preferred binding sites
for MT on Aβ . The authors associated four distinct peaks
with Aβ42 alone, while in the presence of a 10-fold CLR01-
excess three sets of peaks occurred corresponding to different
charge states of the complexes of Aβ42 with up to four bound
tweezers (Bernstein et al., 2009). No dimers or higher oligomers
were observed (Figure 2D). This is a good indication that
CLR01 not only prevents formation of Aβ42 dimers, but also
of higher order oligomers. Importantly, no free, unbound Aβ42
was found in the mass spectrum, supporting the assumption
that MT bind directly to Aβ42 with rather high affinity (∼ 1
µM). The authors concluded that CLR01 can remodel the early
oligomerization of Aβ42 not only immediately upon dissolution
Frontiers in Chemistry | www.frontiersin.org 6 October 2019 | Volume 7 | Article 657
Hadrovic et al. Molecular Tweezers Against Protein Aggregation
but also after the oligomers have already been formed (Zheng
et al., 2015).
Native Top-Down Mass Spectrometry and IMS were likewise
used to characterize the interaction between MT and the Tau
Protein (Nshanian et al., 2018).
Very recently, Loo also reported that no toxic oligomers are
left as the result of the efficient interaction between MT and
SOD1 (Superoxide Dismutase 1).With ECD, the covalent peptide
bonds of the polypeptide could be cleaved, whereas non-covalent
forces sufficed to hold the ligand bound to the macromolecule.
Tandem MS (MS/MS) or “top-down” MS of the protein–ligand
complex allowed to explore the main binding site(s) of MT on
the SOD1 surface. Surprisingly, MT preferred to bind to Lys-70
and/or Lys-75 although none of these residues is directly involved
in the aggregation process of SOD1. This may explain why at least
a 5-fold MT excess is required to affect the aggregation (Malik
et al., 2019).
In this investigation, CLR01 inhibited abnormal SOD1 self-
assembly in vitro, as well as in vivo, as being shown on the G93A-
SOD1 mouse model of amyotrophic lateral sclerosis (ALS). By
applying therapeutic amounts of CLR01 to recombinant wild
type and mutant SOD1, their in vitro aggregation speed was
significantly lowered for all SOD1 forms. In vivo, misfolded
SOD1 in the spinal cord was significantly reduced, yet not
enough to overcome motor deficits, most likely due to the
fast disease progression. Further insight came from experiments
on SOD1 with ThT and EM at the end of each aggregation.
For a potential SOD1 treatment, advanced tweezer derivatives
with improved performance must be designed in the future
(Malik et al., 2019).
CONCLUSION AND OUTLOOK
The above-discussed synopsis of structural and biophysical
experiments strongly suggests that molecular tweezers dock onto
sterically accessible lysine and arginine on aggregating proteins.
The resulting Lys/Arg shielding prevents misfolding and/or
subsequent protein aggregation into toxic oligomers. It also
dissolves existing β-sheets and redirects their path of aggregation
to benign amorphous structures.
The same effects are observed with a large number of
aggregating proteins, so that these lysine binders seem to act in
a process-specific manner and are clearly not protein-specific.
In all cases where lysine or arginine residues are involved in
the aggregation process, molecular tweezers seem to prevent
their ordered aggregation into fibrillar toxic structures. It may
be argued that unselective multiple lysine binding should greatly
disturb protein function; however, their moderate affinity (10–30
µM Kd) and fast on- and off-rates apparently preserve natural
protein folding and function. Indeed, for enzyme inhibition 100-
fold higher concentrations are needed (1 mM), providing a large
potential therapeutic window.
After the initial aggregation assays with isolated proteins, cell
culture experiments demonstrated powerful protection against
oligomer or fibril lesion from exactly those proteins whose
aggregation could also be rescued in vitro (Xu et al., 2017; Malik
et al., 2018). Finally, triply transgenic mice were treated with low
daily doses of CLR01 (40 µg/kg) and showed dramatic reduction
of plaque load in their cortices (stained histological brain slices).
Subsequent behavioral tests (Y-Maze, Pole climbing) revealed
significant memory and mobility improvement after treatment
with CLR01 (Richter et al., 2017).
Although no systematic metabolism studies have been carried
out yet, no degradation product could be found so far, e.g.,
after treatment with strong acid (pH 0) and base (pH 12) and
common phosphatases. We assume that the steric demand of
the tweezer skeleton prevents most chemical transformations at
the two phosphate groups, and that the doubly phosphorylated
stage is recognized as a water-soluble metabolite ready for
urinary excretion.
CLR01 was tritium-labeled and could be detected in mouse
brains. In addition, HPLC-MS assays of brain extracts revealed
2-3 nM concentrations of CLR01. We are currently optimizing
the tweezer structure to generate aggregation inhibitors of lower
polarity which will cross the blood-brain barrier (BBB) much
more efficiently, hopefully even after oral administration. In some
of these projects the results are so promising that we hope to enter
clinical trial within the next few years.
Thus, a supramolecular host molecule for basic amino
acids was turned into a powerful tool against pathologic
protein aggregation and showed highly promising effects in
various cell types and animal models. This is an outstanding
example in the evolution of supramolecular concepts toward
biological application.
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